0 results for 'Mallinckrodt Pharmaceuticals'
Court rejected invocation of securities safe harbor provision to dismiss fraudulent transfer claims where defendant did not qualify as a financial participant in the transaction as defined by the provision.
A Full Slate of Litigator of the Week Runners-Up and Shout Outs
A trial team at Panish | Shea | Boyle | Ravipudi won a $135 million damages verdict for two California men who were sexually abused by their sixth-grade teacher starting in 1996 in a case where the school district was on notice of other child molestation complaints against the teacher years earlier.Litigation Department of the Year Winner: Latham & Watkins
"Latham's litigation department is not just a constellation of top-tier practice groups, but also a genuinely collaborative team that works across practice areas to secure extraordinary results for clients."Pharmaceutical Co. Sues Insurer Over Failure to Indemnify It in Opioid Litigation
Hikma Pharmaceuticals claimed Lloyd's of London has breached a policy to provide coverage given proper notice.State Attorneys General Flexing Muscles, Posing Growing Risk to Legal Departments
"When acting together, they're another FTC but maybe even worse," said Lori Kalani, co-chair of the state attorneys general practice at Cozen O'Connor.View more book results for the query "Mallinckrodt Pharmaceuticals"
Pharma Board Faces Shareholder Class Action for Opioid Settlements
The plaintiff claimed that Mallinckrodt PLC's board of directors caused class members' stock to lose all value, in part by "refusing to aggressively litigate or vigorously defend opioid lawsuits."Health Care Fraud Tops DOJ's Annual False Claims Act Report—Again!
In this article, insurance fraud columnist Michael A. Sirignano explores the health care-related information in the report in more depth and then discusses how this helps to understand the federal government's FCA enforcement priorities, as well as the priorities that private insurers should be contemplating.Defendants moved to dismiss lead plaintiff's complaint.
'The Human Side:' Shook Hardy Partner Exits to Lead Legal Services Group
"I've checked all the boxes on the private practice side and was really looking for a new challenge," said Matthew Keenan.A patent licensor could issue a license to a future continuation patent that was ultimately not issued to the licensor by expressly including future continuation patents in the scope of the license since permitting the eventual patent owner to sue for infringement of the continuation patent would undermine rights acquired for consideration by the licensee.
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now
Countdown to Compliance: SEC Private Fund Reforms
Brought to you by Ontra
Download Now